Acute effects of nicotine on arterial stiffness and wave reflection in healthy young non-smokers.

Plain-language guide to PMID 19207722 (2009): double-blind randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID: 19207722
Journal: Clinical and experimental pharmacology & physiology
Year: 2009
Study type: Randomized Controlled Trial
Authors: Adamopoulos D et al. (6 authors)
DOI: 10.1111/j.1440-1681.2009.05141.x

What This Study Did, in Plain Language

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

Each subject underwent repeated measurements at baseline and for 1 h after nicotine or placebo intake, using carotid-femoral pulse wave velocity (PWV) to assess arterial compliance.

Why It Was Studied

However, the exact contribution of nicotine to the smoke-induced enhancement of wave reflection and the potential underlying mechanisms have not been fully investigated. 2.

The present study was a prospective study in 15 healthy male non-smokers.

Who Took Part

The age groups tagged for this paper are young adults, men only.

Concurrently, aortic pressures and the augmentation index were evaluated using applanation tonometry. 3.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and crossover study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Therapeutic nicotine (patch, non-peptide).

The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.

In the crossover set-up each of the participants took both Therapeutic nicotine (patch, non-peptide) and the comparison in turn, acting as their own control.

What Was Measured

Topics PubMed links to this paper include Aorta, Blood Pressure, Carotid Arteries, Elasticity, Femoral Artery, Heart Rate and Hemodynamics.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2009 (Clinical and experimental pharmacology & physiology), a journal based in Australia.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Therapeutic nicotine (patch, non-peptide) in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.